Anti-Cancer Drugs
Country
United States
Northern America
Subject Area and Category
Biochemistry, Genetics and Molecular Biology
└
Oncology
Q3
└
Pharmacology
Q3
└
Pharmacology (medical)
Q3
Publisher
SJR 2025
0.506
Q3
SJR Score
H-Index
106
Citations / Doc (2yr)
1.96
Total Docs. (latest)
106
Total Citations (3yr)
1,033
Publication type
Journals
ISSN
09594973, 14735741
Coverage
1990-2026
Journal Rank
#11,762
Subject Categories
Oncology
Q3
Pharmacology
Q3
Pharmacology (medical)
Q3
Cancer Research
Q4
Subject Areas
Detailed Metrics
| Total Docs. (latest) | 106 |
| Total Docs. (3 years) | 517 |
| Total Refs. | 3,015 |
| Total Citations (3 years) | 1,033 |
| Citable Docs. (3 years) | 515 |
| Citations / Doc. (2 years) | 1.96 |
| Ref. / Doc. | 28.44 |
| % Female | 46.0% |
Metrics Visualization
Latest year data vs 3-year cumulative figures
Publication & Citation Trend
Loading trend data from Crossref...
Top 10 Most Cited Articles
Loading articles...
Frequently Asked Questions
What is the impact factor of Anti-Cancer Drugs?
The official Journal Impact Factor (JIF) is published by Clarivate in the Journal Citation Reports (JCR) and is not listed on this page. Based on SCImago data, Anti-Cancer Drugs has an SJR of 0.506 and is ranked Q3.
What is the SJR and quartile of Anti-Cancer Drugs?
Anti-Cancer Drugs has an SJR (SCImago Journal Rank) of 0.506 and its best quartile is Q3.
What is the H-index of Anti-Cancer Drugs?
The H-index of Anti-Cancer Drugs is 106, meaning 106 of its articles have each been cited at least 106 times.
Is Anti-Cancer Drugs indexed in Scopus?
Yes. Anti-Cancer Drugs is active in Scopus (Scopus Source List, August 2026).
Researcher Reviews
Write a ReviewNo reviews yet for this journal.
Be the first to share your experience!
Share Your Experience
Your review will be published after moderation. Email will not be displayed publicly.